Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cátia Rocha
Observed names:
C Rocha,
C. Rocha,
Catia Rocha,
Cátia L. Rocha,
Rocha, Cátia
Institutions:
University of Lisbon,
University of Algarve
Observed institutions:
University of Lisbon,
Universidade do Porto,
Instituto Superior Técnico,
Centro de Estatística e Aplicações,
University of Algarve
ORCID:
0000-0002-6247-1794
Observed ORCID:
0000-0002-6247-1794
OpenAlex ID:
A5012173299
Works
20
Awards
1
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review
2019
·
Maria Manuela Estevinho
, Cátia Rocha
, et al.
·
Clinical Gastroenterology and Hepatology
·
61
Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms
2021
·
Bella Ungar
, Karin Malickova
, et al.
·
Journal of Crohn s and Colitis
·
39
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease
2020
·
Pedro Pinto-Lopes
, Joana Afonso
, et al.
·
Inflammatory Bowel Diseases
·
29
Accuracy of the new rapid test for monitoring adalimumab levels
2019
·
Cátia Rocha
, Joana Afonso
, et al.
·
Therapeutic Advances in Gastroenterology
·
19
PDF
Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
2020
·
Cátia Rocha
, Paula Lago
, et al.
·
Therapeutic Advances in Gastroenterology
·
14
PDF
Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
2021
·
Pedro Pinto-Lopes
, Francisco Melo
, et al.
·
Clinical and Translational Gastroenterology
·
13
The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels
2018
·
F. Magro
, C. Rocha
, et al.
·
Therapeutic Advances in Gastroenterology
·
9
PDF
Identification of candidate causal variants and target genes at 41 breast cancer risk loci through differential allelic expression analysis
2024
·
Joana M. Xavier
, Ramiro Magno
, et al.
·
Scientific Reports
·
3
PDF
Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer
2022
·
Filipa Esteves
, Joana M. Xavier
, et al.
·
European Journal of Cancer
·
3
PDF
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the intervention
2020
·
B Ungar
, K Malickova
, et al.
·
Journal of Crohn s and Colitis
·
3
PDF
P229 The new biosimilar of infliximab SB2 can be quantified by IFX-optimised therapeutic drug monitoring assays
2018
·
F Magro
, C Rocha
, et al.
·
Journal of Crohn s and Colitis
·
3
Abstract A31: Integrative differential allelic expression analysis efficiently reveals the biology underlying risk to breast cancer
2016
·
Joana Xavier
, Roslin Russell
, et al.
·
Molecular Cancer Research
·
3
Dark Proteome Database: Studies on Disorder
2020
·
Nelson Perdigão
, Pedro M. C. Pina
, et al.
·
Microarrays
·
2
PDF
Insights into tuberculosis: A survival analysis of time to recurrence in Portugal, between 2002 and 2009
2020
·
P. Soares
, R. Duarte
, et al.
·
Pulmonology
·
1
PDF
Sa1867 LOWER VEDOLIZUMAB TROUGH LEVELS BEFORE INTERVAL SHORTENING ARE NOT PREDICTIVE OF SUCCESS OF THE INTERVENTION
2020
·
Bella Ungar
, Karin Malíčková
, et al.
·
Gastroenterology
P113 Accuracy of a new rapid test assay for monitoring adalimumab levels
2019
·
J Afonso
, C Rocha
, et al.
·
Journal of Crohn s and Colitis
Show more works
View as search
Works count:
20
Citation count:
202
H-index:
7
I10-index:
6
Year
Topic
Type